VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
11 hedge funds and large institutions have $74K invested in VIVEVE MED INC in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
15% less funds holding
Funds holding: 13 → 11 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
92% less capital invested
Capital invested by funds: $905K → $74K (-$831K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$66.9K |
| 2 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
+$12.4K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$1.51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.09K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$549K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$121K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$81.4K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$69K |
| 5 |
5VM
5AM Venture Management
San Francisco,
California
|
-$10K |
VIVE Hedge Fund Activity: Q1 2020 in Review
11 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2020, worth a combined $74K — down 92% from $905K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VIVE and 4 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $66.9K. The largest seller was HighTower Advisors, exiting entirely with an estimated $549K sold.
- 11 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2020, down from 13 in Q4 2019.
- Funds reported $74K of VIVEVE MED INC stock for Q1 2020, down 92% quarter-over-quarter.
- 4 funds opened new VIVEVE MED INC positions in Q1 2020 and 5 closed out, a net change of -1 holder.
- The largest VIVEVE MED INC buyer in Q1 2020 was Renaissance Technologies, an estimated $66.9K added.
- The largest VIVEVE MED INC seller in Q1 2020 was HighTower Advisors, an estimated $549K sold.
Based on aggregated 13F filings for Q1 2020.